Literature DB >> 21310168

Effects of manganese on tyrosine hydroxylase (TH) activity and TH-phosphorylation in a dopaminergic neural cell line.

Danhui Zhang1, Arthi Kanthasamy, Vellareddy Anantharam, Anumantha Kanthasamy.   

Abstract

Manganese (Mn) exposure causes manganism, a neurological disorder similar to Parkinson's disease. However, the cellular mechanism by which Mn impairs the dopaminergic neurotransmitter system remains unclear. We previously demonstrated that caspase-3-dependent proteolytic activation of protein kinase C delta (PKCδ) plays a key role in Mn-induced apoptotic cell death in dopaminergic neurons. Recently, we showed that PKCδ negatively regulates tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis, by enhancing protein phosphatase-2A activity in dopaminergic neurons. Here, we report that Mn exposure can affect the enzymatic activity of TH, the rate-limiting enzyme in dopamine synthesis, by activating PKCδ-PP2A signaling pathway in a dopaminergic cell model. Low dose Mn (3-10μM) exposure to differentiated mesencephalic dopaminergic neuronal cells for 3h induced a significant increase in TH activity and phosphorylation of TH-Ser40. The PKCδ specific inhibitor rottlerin did not prevent Mn-induced TH activity or TH-Ser40 phosphorylation. On the contrary, chronic exposure to 0.1-1 μM Mn for 24h induced a dose-dependent decrease in TH activity. Interestingly, chronic Mn treatment significantly increased PKCδ kinase activity and protein phosphatase 2A (PP2A) enzyme activity. Treatment with the PKCδ inhibitor rottlerin almost completely prevented chronic Mn-induced reduction in TH activity, as well as increased PP2A activity. Neither acute nor chronic Mn exposures induced any cytotoxic cell death or altered TH protein levels. Collectively, these results demonstrate that low dose Mn exposure impairs TH activity in dopaminergic cells through activation of PKCδ and PP2A activity.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21310168      PMCID: PMC3107879          DOI: 10.1016/j.taap.2010.03.023

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  49 in total

Review 1.  Regulatory mechanism of tyrosine hydroxylase activity.

Authors:  Hitoshi Fujisawa; Sachiko Okuno
Journal:  Biochem Biophys Res Commun       Date:  2005-08-10       Impact factor: 3.575

2.  Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models.

Authors:  Faneng Sun; Vellareddy Anantharam; Danhui Zhang; Calivarathan Latchoumycandane; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Neurotoxicology       Date:  2006-06-29       Impact factor: 4.294

3.  The Manganese Health Research Program (MHRP): status report and future research needs and directions.

Authors:  M Aschner; B Lukey; A Tremblay
Journal:  Neurotoxicology       Date:  2005-12-02       Impact factor: 4.294

4.  Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates.

Authors:  Tomás R Guilarte; Ming-Kai Chen; Jennifer L McGlothan; Tatyana Verina; Dean F Wong; Yun Zhou; Mohab Alexander; Charles A Rohde; Tore Syversen; Emmanuel Decamp; Amy Jo Koser; Stephanie Fritz; Heather Gonczi; David W Anderson; Jay S Schneider
Journal:  Exp Neurol       Date:  2006-08-22       Impact factor: 5.330

5.  Manganese does not alter the severe neurotoxicity of MPTP.

Authors:  S Y Baek; Y H Kim; S O Oh; C-R Lee; C I Yoo; J H Lee; H Lee; C S Sim; J Park; J-W Kim; C S Yoon; Y Kim
Journal:  Hum Exp Toxicol       Date:  2007-03       Impact factor: 2.903

6.  Protein kinase Cdelta is a key downstream mediator of manganese-induced apoptosis in dopaminergic neuronal cells.

Authors:  Calivarathan Latchoumycandane; Vellareddy Anantharam; Masashi Kitazawa; Yongjie Yang; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  J Pharmacol Exp Ther       Date:  2004-12-17       Impact factor: 4.030

Review 7.  Manganese neurotoxicity: a focus on the neonate.

Authors:  Keith M Erikson; Khristy Thompson; Judy Aschner; Michael Aschner
Journal:  Pharmacol Ther       Date:  2006-09-22       Impact factor: 12.310

8.  Manganese-induced neurotoxicity: the role of astroglial-derived nitric oxide in striatal interneuron degeneration.

Authors:  Xuhong Liu; Kelly A Sullivan; James E Madl; Marie Legare; Ronald B Tjalkens
Journal:  Toxicol Sci       Date:  2006-03-21       Impact factor: 4.849

9.  Oxidative stress and mitochondrial-mediated apoptosis in dopaminergic cells exposed to methylcyclopentadienyl manganese tricarbonyl.

Authors:  Masashi Kitazawa; Jarrad R Wagner; Michael L Kirby; Vellareddy Anantharam; Anumantha G Kanthasamy
Journal:  J Pharmacol Exp Ther       Date:  2002-07       Impact factor: 4.030

10.  A child with chronic manganese exposure from drinking water.

Authors:  Alan Woolf; Robert Wright; Chitra Amarasiriwardena; David Bellinger
Journal:  Environ Health Perspect       Date:  2002-06       Impact factor: 9.031

View more
  24 in total

1.  Manganese-induced NF-kappaB activation and nitrosative stress is decreased by estrogen in juvenile mice.

Authors:  Julie A Moreno; Karin M Streifel; Kelly A Sullivan; William H Hanneman; Ronald B Tjalkens
Journal:  Toxicol Sci       Date:  2011-04-21       Impact factor: 4.849

2.  Expression of synaptophysin protein in different dopaminergic cell lines.

Authors:  Xiang Bai; Randy Strong
Journal:  J Biochem Pharmacol Res       Date:  2014-12

3.  Manganese-Mediated Decrease in Levels of c-RET and Tyrosine Hydroxylase Expression In Vitro.

Authors:  Mayuko Y Kumasaka; Ichiro Yajima; Nobutaka Ohgami; Hiromasa Ninomiya; Machiko Iida; Xiang Li; Reina Oshino; Hiroko Tanihata; Masafumi Yoshinaga; Masashi Kato
Journal:  Neurotox Res       Date:  2017-07-20       Impact factor: 3.911

4.  Methamphetamine-induced neurotoxicity linked to ubiquitin-proteasome system dysfunction and autophagy-related changes that can be modulated by protein kinase C delta in dopaminergic neuronal cells.

Authors:  M Lin; P Chandramani-Shivalingappa; H Jin; A Ghosh; V Anantharam; S Ali; A G Kanthasamy; A Kanthasamy
Journal:  Neuroscience       Date:  2012-03-14       Impact factor: 3.590

5.  The transcription factor REST up-regulates tyrosine hydroxylase and antiapoptotic genes and protects dopaminergic neurons against manganese toxicity.

Authors:  Edward Pajarillo; Asha Rizor; Deok-Soo Son; Michael Aschner; Eunsook Lee
Journal:  J Biol Chem       Date:  2020-01-30       Impact factor: 5.157

6.  17β-estradiol and tamoxifen protect mice from manganese-induced dopaminergic neurotoxicity.

Authors:  Edward Pajarillo; James Johnson; Judong Kim; Pratap Karki; Deok-Soo Son; Michael Aschner; Eunsook Lee
Journal:  Neurotoxicology       Date:  2017-11-26       Impact factor: 4.294

7.  Phosphatidylinositol 3 kinase (PI3K) modulates manganese homeostasis and manganese-induced cell signaling in a murine striatal cell line.

Authors:  Miles R Bryan; Michael A Uhouse; Kristen D Nordham; Piyush Joshi; Daniel I R Rose; Michael T O'Brien; Michael Aschner; Aaron B Bowman
Journal:  Neurotoxicology       Date:  2017-08-02       Impact factor: 4.294

8.  Effect of olfactory manganese exposure on anxiety-related behavior in a mouse model of iron overload hemochromatosis.

Authors:  Qi Ye; Jonghan Kim
Journal:  Environ Toxicol Pharmacol       Date:  2015-06-23       Impact factor: 4.860

9.  Manganese nanoparticle activates mitochondrial dependent apoptotic signaling and autophagy in dopaminergic neuronal cells.

Authors:  Hilary Afeseh Ngwa; Arthi Kanthasamy; Yan Gu; Ning Fang; Vellareddy Anantharam; Anumantha G Kanthasamy
Journal:  Toxicol Appl Pharmacol       Date:  2011-08-05       Impact factor: 4.219

10.  Ginsenoside Re rescues methamphetamine-induced oxidative damage, mitochondrial dysfunction, microglial activation, and dopaminergic degeneration by inhibiting the protein kinase Cδ gene.

Authors:  Eun-Joo Shin; Seung Woo Shin; Thuy-Ty Lan Nguyen; Dae Hun Park; Myung-Bok Wie; Choon-Gon Jang; Seung-Yeol Nah; Byung Wook Yang; Sung Kwon Ko; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Mol Neurobiol       Date:  2014-01-16       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.